Health Care: Drugs

Tekmira Pharmaceuticals Corp (TKMR: NASDAQ)

$13.09 -0.23 | -1.73%
12/22/14 - 12:10 PM ET
Company Profile
Price and Volume
Recent Price 13.32
52 Week High 31.48
52 Week Low 7.46
Avg. Daily Vol. (Mil) 3.10
Beta (3 year) 1.36
Share Related Items
Mkt Cap (Mil) 297.22
Shares Out (Mil) 22.31
Float (Mil) 21.15
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 5.70
Current Ratio 5.70
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 16.38
Price/Book 3.11
Price/Cash Flow -8.60
Per Share Data
Earnings -1.70
Sales 0.81
Book Value 4.28
Cash Flow -1.56
Business Summary
Tekmira Pharmaceuticals Corp develops ribonucleic acid interference therapeutic product candidates as well as provides its lipid nanoparticle delivery technology to pharmaceutical partners in the Canada.
General Information
100 - 8900 Glenlyon Parkway
Burnaby, BC V5J 5J8
www.tekmirapharm.com
Industry : Drugs
Sector: Health Care
Employees: 92
CEO: Dr. Mark J. Murray,PhD
Short Interest
Current Month (Mil) 2.48
Previous Month (Mil) 2.70
Short Interest Ratio (Days) 2.50
Management Effectiveness
Return on Equity n.a.
Return on Assets -28.20
Return on Investments -36.90
Profitability
Gross Margin -86.30
EBIT Margin n.a.
Profit Margin 0.00

Partner Headlines for TKMR

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter